Categories: News

Verisante Share Consolidation Effective

VANCOUVER, BC / ACCESSWIRE / June 23, 2022 / Verisante Technology Inc. (the “Corporation”) (TSXV:VRS.H) announces that as of June 23, 2022, the common shares of the Corporation will commence trading on a post-Consolidation basis under the new ticker symbol VER.H on the NEX board of the TSX-V Exchange. the Corporation will undertake a consolidation (“Consolidation”) of its outstanding common shares on the basis of one (1) post-Consolidation Share for every ten (10) pre-Consolidation shares. The Consolidation has been approved by the directors of the Corporation, in accordance with the Articles of the Corporation.

As of the date of this news release, the Corporation has 98,615,888 common shares issued and outstanding. Following completion of the Consolidation, the Corporation is expected to have approximately 9,861,588 common shares issued and outstanding. The 15,354,182 common shares issuable upon TSX-V Exchange acceptance of the Corporation’s proposed shares for debt and private placement announced on June 6, 2022, will also be proportionally adjusted upon completion of the Consolidation. The Corporation has no preferred shares, warrants or options outstanding.

A letter of transmittal will be mailed to registered shareholders once the Consolidation has taken effect. The letter of transmittal contains instructions on how registered shareholders can exchange their share certificates evidencing their pre-Consolidation shares for new share certificates representing the number of post-Consolidation shares to which they are entitled.

Beneficial shareholders holding their shares through a brokerage may be subject to different procedures for obtaining their post-Consolidation shares. If shareholders have any questions in this regard, they are encouraged to contact their respective brokerage or intermediary.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Company Contact:

Thomas Braun, President & CEO
Verisante Technology, Inc.
Telephone: (604) 716-5133
Email: info@verisante.com

Forward Looking Statements:

This release contains forward-looking statements all of which statements are subject to market risks, and the possibility that the Corporation will not be able to achieve all of its stated goals. These statements are made based upon current expectations and actual results may differ from those projected due to a number of risks and uncertainties.

SOURCE: Verisante Technology, Inc.

View source version on accesswire.com:
https://www.accesswire.com/706229/Verisante-Share-Consolidation-Effective

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

11 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

11 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago